 |
MorphoSys AG
MOR
|
33.4 M |
- |
2.43 % |
$ 254 M |
Germany |
 |
Acorda Therapeutics
ACOR
|
1.24 M |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
19.8 M |
- |
- |
$ 86.2 M |
USA |
 |
ACADIA Pharmaceuticals
ACAD
|
166 M |
$ 22.56 |
2.13 % |
$ 3.74 B |
USA |
 |
AlloVir
ALVR
|
15.3 M |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M |
- |
- |
$ 10.1 M |
USA |
 |
Applied Therapeutics
APLT
|
84.2 M |
- |
- |
$ 8.42 M |
USA |
 |
Akebia Therapeutics
AKBA
|
257 M |
$ 1.43 |
3.62 % |
$ 368 M |
USA |
 |
argenx SE
ARGX
|
51.1 M |
$ 785.07 |
2.57 % |
$ 25 B |
Niderland |
 |
I-Mab
IMAB
|
187 M |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
44.7 B |
- |
2.54 % |
$ 160 B |
France |
 |
Alnylam Pharmaceuticals
ALNY
|
131 M |
$ 327.25 |
2.42 % |
$ 42.9 B |
USA |
 |
Biophytis SA
BPTS
|
118 M |
- |
-13.47 % |
$ 169 M |
France |
 |
Aytu BioScience
AYTU
|
6.28 M |
$ 2.66 |
3.5 % |
$ 16.7 M |
USA |
 |
AVROBIO
AVRO
|
44.3 M |
- |
1083.1 % |
$ 745 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
1.42 B |
- |
- |
$ 96.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
80.5 M |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
1.42 B |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B |
$ 3.9 |
3.7 % |
$ 9.38 B |
Australia |
 |
CymaBay Therapeutics
CBAY
|
106 M |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
6.02 M |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
46.7 M |
$ 20.4 |
-0.87 % |
$ 954 M |
USA |
 |
Aquestive Therapeutics
AQST
|
107 M |
$ 4.18 |
1.21 % |
$ 447 M |
USA |
 |
Avid Bioservices
CDMO
|
63.2 M |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
6.35 M |
- |
- |
$ 1.41 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M |
- |
- |
- |
Russia |
 |
Arcutis Biotherapeutics
ARQT
|
127 M |
$ 24.61 |
5.76 % |
$ 3.13 B |
USA |
 |
Cabaletta Bio
CABA
|
100 M |
$ 3.09 |
0.65 % |
$ 310 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
39.7 M |
- |
- |
$ 169 M |
USA |
 |
Aeterna Zentaris
AEZS
|
115 M |
- |
5.93 % |
$ 314 M |
Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
21.6 M |
- |
- |
$ 231 M |
USA |
 |
AgeX Therapeutics
AGE
|
10.2 M |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
34.4 M |
- |
- |
$ 401 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M |
- |
- |
$ 26.5 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
266 M |
$ 1.49 |
9.56 % |
$ 397 M |
Britain |
 |
CTI BioPharma Corp.
CTIC
|
115 M |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
14.3 M |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
2.45 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.19 M |
- |
-4.36 % |
$ 27 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
85.1 M |
- |
- |
$ 2.18 B |
USA |
 |
Akero Therapeutics
AKRO
|
67.1 M |
- |
- |
$ 3.67 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
130 M |
- |
- |
$ 2.02 B |
USA |
 |
Forte Biosciences
FBRX
|
12.9 M |
$ 26.27 |
0.38 % |
$ 340 M |
USA |
 |
CureVac N.V.
CVAC
|
186 M |
- |
- |
$ 867 M |
Germany |
 |
Akari Therapeutics, Plc
AKTX
|
67.3 B |
$ 3.88 |
2.11 % |
$ 261 B |
Britain |
 |
Akouos
AKUS
|
34.4 M |
- |
0.23 % |
$ 488 M |
USA |